2026 NPPES data Clinical Genetics (M.D.) Physician NPI 1548362759 M.D., M.S.
Verify on CMS →

MANISHA BALWANI, M.D., M.S.

Clinical Genetics (M.D.) Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
12
Medicare Part D claims · Clinical Genetics (M.D.) Physician avg: 261
Generic prescribing
0%
generic claims · 100% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$27.4K
35 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MANISHA BALWANI, M.D., M.S. filed 12 Medicare Part D claims in 2023 as a Clinical Genetics (M.D.) Physician in NEW YORK, New York, prescribing 0% generic.

12
Part D claims, 2023
0%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MANISHA BALWANI, M.D., M.S.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

12 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MANISHA BALWANI, M.D., M.S. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MANISHA BALWANI, M.D., M.S.?

Quality data not reported

NPI registry status

Active

Issued 09/01/2006

NPI 1548362759

Primary specialty

Clinical Genetics (M.D.) Physician

Niche

825 US NPIs in this specialty

Medicare Part D claims

12 95% vs specialty avg

2023 prescription claims

Specialty avg: 261

Specialty distribution in New York

How Clinical Genetics (M.D.) Physician compares to other specialties among New York providers

New York providers

Clinical Genetics (M.D.) Physician share within New York

1. Clinical Genetics (M.D.) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Clinical Genetics (M.D.) Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Clinical Genetics (M.D.) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Clinical Genetics (M.D.) Physician ABMS/AOA estimate

Est. board-certified rate (Clinical Genetics (M.D.) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Clinical Genetics (M.D.) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MANISHA BALWANI, M.D., M.S. appears in the CMS NPPES registry as a Clinical Genetics (M.D.) Physician provider holding M.D., M.S. credentials at 1184 FIFTH AVENUE, NEW YORK, NY, 10029, with a listed phone of (212) 241-0915. NPI 1548362759 was issued on 09/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BALWANI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 12 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $342K in drug spend, split 100% brand-name and 0% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Clinical Genetics (M.D.) Physician is a narrow specialty nationwide, with 825 enrolled providers across 50 states and an average of 261 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1184 FIFTH AVENUE
NEW YORK, NY 10029

Provider Details

NPI 1548362759
Specialty Clinical Genetics (M.D.) Physician
Credentials M.D., M.S.
Gender Female
NPI Issued 09/01/2006

Hospital and facility affiliations

Facilities where MANISHA BALWANI, M.D., M.S. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NEW YORK, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MANISHA BALWANI, M.D., M.S.. Source: openpaymentsdata.cms.gov.

Total received

$27.4K

Largest payer

GENZYME CORPORATION

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MANISHA BALWANI, M.D., M.S.. To verify MANISHA BALWANI, M.D., M.S.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

MANISHA BALWANI, M.D., M.S. — brand share 100.0%
Specialty average (est.)

100% brand-name claims vs 0% generic, on 12 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

12
Total Claims
$342K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
12
Total Day Supply
280
Brand vs Generic
100% brand / 0% generic
Brand Drug Cost
$342K
Generic Drug Cost
$0

Patient Demographics

Average Patient Age
71.0 years
Avg HCC Risk Score
1.06

Clinical Genetics (M.D.) Physician Overview

How MANISHA BALWANI, M.D., M.S. fits within the Clinical Genetics (M.D.) Physician landscape nationally.

825
Clinical Genetics (M.D.) Physician Providers in US
50
States with Clinical Genetics (M.D.) Physician
261
Avg Claims per Provider

MANISHA BALWANI, M.D., M.S.'s 12 claims are below the specialty average of 261.

Nearby Clinical Genetics (M.D.) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as BALWANI.

Compare Clinical Genetics (M.D.) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MANISHA BALWANI, M.D., M.S.'s specialty?
MANISHA BALWANI, M.D., M.S. specializes in Clinical Genetics (M.D.) Physician and practices in NEW YORK, New York. Credentials: M.D., M.S..
How much does MANISHA BALWANI, M.D., M.S. prescribe under Medicare Part D?
In 2023, MANISHA BALWANI, M.D., M.S. wrote 12 Medicare Part D claims totaling $342K in drug costs for N/A beneficiaries.
Where is MANISHA BALWANI, M.D., M.S. located?
MANISHA BALWANI, M.D., M.S. is located at 1184 FIFTH AVENUE, NEW YORK, NY, 10029. Phone: (212) 241-0915.
What is MANISHA BALWANI, M.D., M.S.'s NPI number?
MANISHA BALWANI, M.D., M.S.'s National Provider Identifier (NPI) is 1548362759, issued on 09/01/2006.
Does MANISHA BALWANI, M.D., M.S. prescribe more brand-name or generic drugs?
MANISHA BALWANI, M.D., M.S.'s prescribing is 100% brand-name and 0% generic drugs by claim count, with $342K in brand drug costs.
How many Clinical Genetics (M.D.) Physician providers are there in the US?
There are 825 Clinical Genetics (M.D.) Physician providers across 50 states in the US. The average Clinical Genetics (M.D.) Physician provider writes 261 Medicare Part D claims per year.
Does MANISHA BALWANI, M.D., M.S. accept Medicare?
MANISHA BALWANI, M.D., M.S. appears in CMS Medicare data with 12 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MANISHA BALWANI, M.D., M.S.'s credentials?
MANISHA BALWANI, M.D., M.S.'s NPI is 1548362759 with credentials M.D., M.S.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology